Tris Pharma · 6 days ago
Manager, Accounting
Tris Pharma, Inc. is a leading privately-owned U.S. biopharmaceutical company focused on innovative medicines in ADHD and other therapeutic areas. The Manager, Accounting will work closely with senior management to ensure accurate financial records and compliance with GAAP, while overseeing financial reporting and internal controls.
BiotechnologyLife ScienceManufacturingMedicalPharmaceutical
Responsibilities
Prepares and/or reviews appropriate general ledger entries and account reconciliations
Manages company’s financial accounts, internal controls, payrolls, cash receipts and financial assets for timeliness, compliance and accuracy
Prepares monthly, quarterly and annual consolidated financial statements; Assists with regulatory reporting, as applicable
Researches and corrects accounting issues for compliance with GAAP and other appropriate regulations; Proactively reports issues to upper management for resolution, as necessary
Coordinates and participates in internal and external audits, as needed
Participates in interviewing and training new employees and mentors Accounting team members, as needed
Qualification
Required
Certified Public Accountant (CPA) OR in process of obtaining CPA with Bachelors degree in Accounting and a minimum 6 years experience in public industry or corporate accounting REQUIRED
Hands on knowledge of GAAP rules and regulations REQUIRED
Current, hands-on experience performing general accounting functions (i.e., general ledger, reconciliations, monthly/quarterly/annual financial statements, payroll, etc.) REQUIRED
Experience working with external auditors REQUIRED
Strong record keeping ability REQUIRED
Preferred
Accounting experience in the pharmaceutical or biotechnology industry PREFERRED
Benefits
Incentives
Bonus eligible
Medical
Dental
Vision
Rx insurance
401K with match
Life insurance
Paid Company Holidays
PTO
Paid Volunteer Time
Employee Resource Groups
Company
Tris Pharma
Tris Pharma is a pharmaceuticals company providing specialty generic products.
Funding
Current Stage
Late StageTotal Funding
$141.6MKey Investors
National Institute on Drug Abuse (NIDA)Deerfield
2023-08-28Grant· $16.6M
2018-10-05Debt Financing· $125M
Leadership Team
Recent News
Company data provided by crunchbase